The Hershey HSY
Consumer Defensive · Food Confectioners · Synthos Deep Dive · 2026-07-03
The Overview
Hershey makes the candy you already know — Reese's, Hershey's Kisses, Kit Kat, Jolly Rancher, Twizzlers — and, more recently, salty snacks (SkinnyPop, Dot's Pretzels). It is a slow, steady, defensive business: people buy candy in good times and bad. It pays a dividend of about 3.1% every year.
The problem is cocoa. The price of cocoa beans spiked to record levels, and that — plus accounting losses on the contracts Hershey uses to lock in cocoa prices — cut its 2025 reported profit roughly in half. Management is raising candy prices to claw the margin back, and 2026 profit is expected to bounce hard off that low base. But the underlying business barely grows in volume — candy is a mature market.
The stock is down about 23% from its high, so some pain is already priced in. At today's price it looks roughly fairly valued — not the screaming bargain a big drop sometimes signals, and not a growth story. Our verdict is Watch: a fine dividend-paying staple to hold if you already own it, but nothing here demands you buy today.
Here's what our three scores mean in everyday terms:
- Downside Risk 5/10 (middle). The stock barely moves with the market (very low beta) and demand is recession-resistant — but the company carries real debt and just proved cocoa can wreck a year.
- Growth Quality 4/10 (below average). A wonderful brand, but it grows slowly, and 2025's earnings crash shows how exposed the margins are to one commodity.
- Exponential Potential 2/10 (low). This is a mature candy maker. It will not double quickly; expect a dividend plus modest growth.
The one big worry: if cocoa prices stay high (or Hershey's price hikes drive shoppers away), the profit recovery everyone is counting on won't fully happen.
Putting a number on it: our fair-value estimate is $199 against a current price of $179.05 — real upside if our numbers are right.
Our summary metrics
Low beta (0.10) & defensive demand, but 2.1× net-debt/EBITDA and a cocoa-cost shock that halved FY25 EPS.
Low-single-digit organic sales; FY25 earnings collapsed on cocoa/derivatives — the estimates are a recovery, not secular growth.
Mature US confectioner, ~2-5% volume-flat category, no acceleration — a compounder-lite, not an exponential.
What does “fair value” mean?
Fair value is Synthos’s estimate of what one share is worth today, based on our model of the company’s future cash generation and the risks to it. It is not a price target or a prediction of where the stock trades next quarter — it’s the price where we think risk and reward are balanced. Above it, you’re paying for outcomes better than our base case; below it, the market is offering a margin of safety.
The model’s inputs and weightings are proprietary — they’re the product. What we publish is the output, plus an independent, public-math cross-check further down the page (“Check our number”) so you can judge it for yourself.
What do the 5 tiers mean? (Core · Tactical · Watch · Hold · Avoid)
Exponential Potential
Mature US confectioner, ~2-5% volume-flat category, no acceleration — a compounder-lite, not an exponential.
What could take this further than the base case — and where the market may be underpricing it. Full forward-growth and acceleration math in Deeper analysis, §4 below.
Deeper analysis
Technicals, fundamentals, valuation, and the full expert-claim evidence panel — the detail behind the numbers above.
Reference table
| Street consensus | $224 (high $260 / low $182; 8 Buy · 24 Hold · 3 Sell → Hold) — context, not our anchor |
| Valuation | 33× trailing (depressed) EPS · ~22× FY26E adj · ~18× FY27E · ~15× FY30E · EV/S 3.5× · EV/EBITDA 19× |
| Technicals | Downtrend — $182, −23% off 52-wk high, below 50/200-DMA, RSI 51, +3.6% 12-mo (SPY +20.6%) |
| Conviction | Low — 0 expert voices, 0 traceable claims in the Synthos KB; verdict rests on the data |
| Position sizing | Defensive income sleeve only, ~1–2% if owned at all; not a conviction position |
What the experts actually said
No independent expert claims in the Synthos knowledge base yet for HSY — this dive is fundamentals- and technicals-driven, not panel-driven.
Price & moving averages 12 months · 50 & 200-day averages · 52-week range
Solid line = price · dashed line = 50-day average · dotted line = 200-day average · the two thin horizontal lines mark the 52-week high and low. Price above both averages is an uptrend.
Data summary: last close $179.05, 0% above the 50-day average ($179), 7% below the 200-day average ($192) — a mixed trend. 24% below the 52-week high of $236, 10% above the 52-week low of $162.
Bollinger Bands 20-day average ± 2 standard deviations
The shaded band widens when the stock gets more volatile. Riding the upper edge = strong momentum (sometimes stretched); the lower edge = weak / potentially oversold.
Data summary: price $179.05 is currently inside the band (band $177–$190).
RSI (14) momentum gauge · 0–100
Above 70 (overbought zone, shaded) = overbought, below 30 (oversold zone, shaded) = oversold. Currently 45.
MACD 12 / 26 / 9 · trend & momentum
The MACD line crossing above the signal line (bars flip to the up color) = momentum turning up; crossing below (bars flip to the down color) = turning down. Bar height = the size of that gap.
Data summary: MACD is currently below its signal line by 0.64, negative momentum.
Relative performance vs S&P 500 & its sector (XLP (sector)), set to 100 a year ago
Solid = HSY · dashed = S&P 500 · dotted = XLP (sector). A rising line means it is beating that benchmark — the sector line shows whether it is a leader or laggard within its own group.
Forward revenue & earnings actual → estimate · "FY" = fiscal year, "E" = estimate
Darker bars = actual results, brighter = analyst estimates. Taller bars to the right = expected growth.
Key stats an RIA wants
1. What it is
The Hershey Company (NYSE: HSY), founded 1894 and headquartered in Hershey, PA, is the dominant US chocolate and confectionery maker, with an expanding salty-snacks arm. Fiscal year ends the Sunday nearest December 31. CEO is Kirk C. Tanner (ex-PepsiCo), who took the helm in 2024.
Its brand moat is the crown jewel: Hershey's, Reese's, Kisses, Kit Kat (US license), Jolly Rancher, Twizzlers, Ice Breakers, Almond Joy, York, plus snacks under SkinnyPop, Dot's Homestyle Pretzels, Pirate's Booty, Paqui, and LesserEvil (acquired 2025).
Revenue mix (FY2025, from FMP segmentation):
- By product segment: North America Confectionery $9.48B (~81%) · North America Salty Snacks $1.27B (~11%) · (International & Other, from the geographic cut, ~$1.44B / ~12%).
- By geography: North America $10.25B (~88%) · International & Other $1.44B (~12%). This is an overwhelmingly US-centric business — a strength (pricing power in a duopoly-ish chocolate aisle) and a limitation (little geographic growth runway).
The strategic picture: Hershey is a mature, cash-generative staple pulling three levers — (1) price to offset cocoa inflation, (2) salty snacks as the growth adjacency (Salty Snacks organic sales +5.6% in Q1'26 vs low-single-digit confectionery), and (3) productivity (the "Advancing Agility & Automation" program, ~$100M of 2026 savings targeted).
2. The expert thesis (none in the Synthos KB)
There is no expert coverage of HSY in the Synthos knowledge base: total_claims = 0, breadth = 0, net conviction = 0. No net-bullish or cautionary voice we track has published a traceable claim on Hershey. We will not manufacture conviction we do not have.
Accordingly, this verdict is entirely fundamentals- and quant-driven — built from the FMP financials, analyst estimates, price-target and grade data, and management's own SEC 8-K guidance (§9). Where the Street has a view, we show it as context, not anchor: the sell-side is net-neutral on HSY — 8 Buy / 24 Hold / 3 Sell → "Hold", with a $224 consensus target. That Hold consensus is consistent with our own Watch.
3. Synthos scores & the Bull / Base / Bear cases
Three scores, 0–10, each anchored to real metrics (not probabilities we can't honestly calibrate):
| Score | 0–10 | The read |
|---|---|---|
| Downside Risk (lower = safer) | 5 · Moderate | Beta 0.10 and defensive candy demand cushion the downside, but net-debt/EBITDA 2.1× is real leverage and FY25 proved a single input (cocoa) can halve earnings. Valuation isn't stretched, so the risk is operational, not multiple, driven. |
| Growth Quality | 4 · Below average | Organic sales grow low-single-digits (Q1'26 +7.9% organic was mostly +10 pts price / −2 pts volume — i.e. price, not units). ROE 23.7% and ROIC ~11% are respectable, but FY25 net margin cratered to 9.1% on cocoa/derivatives. The forward estimates are a recovery, not secular growth. |
| Exponential Potential | 2 · Low | A mature ~$12B-revenue confectioner in a volume-flat US category. No acceleration (revenue 2nd derivative ~flat), a large cap relative to a small TAM runway. Own it for yield + modest compounding, never for a multibagger. |
The three cases (our own scenario model — assumptions shown; each target is a ~12–18-month fair value). We deliberately do not attach probabilities: the base case is the expected path, so a weighted blend would just restate it with false precision. The cases bound the range; the scores above summarize them. All EPS figures below are adjusted/non-GAAP to strip the cocoa-derivative mark-to-market noise, consistent with how management and the Street frame the recovery.
| Case | Key assumptions | Fair value |
|---|---|---|
| Bull | Cocoa normalizes faster than feared; price hikes stick with limited volume elasticity; salty-snacks momentum continues. FY27E adj EPS beats to ~$10.50 (vs ~$9.96 cons); staple quality earns ~22×. | ~$231 (+27%) |
| Base (our anchor) | Estimates roughly hit — FY27E adj EPS ~$9.96; a durable brand compounder recovering off the cocoa trough earns ~20×. | ~$199 (+9%) |
| Bear | Cocoa stays elevated; price hikes drive worse volume elasticity (GLP-1 appetite-suppression is a live category worry); margin recovery stalls. FY27E adj EPS misses to ~$8.50; multiple de-rates to ~17×. | ~$145 (−20%) |
Synthos fair value = the base case, ~$199 (+9%), with the full $145–$231 span as the honest range. Our base sits below the Street's $224 consensus — we are less willing to pay up for a low-single-digit grower still working through a commodity shock. This is a tracked call — the Forecaster Scorecard grades it once it matures.
4. Exponential Potential
Synthos separates compounders (durable high returns on capital) from exponentials (accelerating, multi-baggers-from-here). HSY is neither an exponential nor even a fast compounder — it is a mature, defensive cash cow:
- Forward growth: revenue CAGR FY25→FY30E ~3.5% ($11.69B → $13.86B, 6 analysts). EPS "CAGR" is optically high only because the FY25 base is cocoa-depressed; on adjusted EPS ($6.31 FY25 → ~$12.41 FY30E) the recovery-plus-growth path is real but front-loaded in the bounce, not secular.
- Acceleration (2nd derivative) is ~flat/negative: revenue growth was +4.4% FY25 and consensus sits at ~+4.8% FY26E, then decelerating toward ~3% by FY30E. There is no inflection — this is a GDP-plus staple. Per our flagship philosophy we pick forward next-exponentials; HSY is the opposite archetype.
- Room to run: the US confectionery TAM is large but volume-flat to declining (health/GLP-1 headwinds), and Hershey is already the category leader. Salty snacks is the only genuine growth adjacency, and at ~11% of revenue it can't move the whole ship fast.
- Reinvestment runway: modest — capex is only ~1.5% of revenue (FY26 guide $425–475M), so this is a return-of-capital story (dividend + buyback), not a reinvest-for-growth story.
Exponential Potential: Low (2/10). Correctly owned as a bond-like income/defensive holding, not a growth or momentum position.
5. Financials (real numbers — FMP annual/quarterly)
- Revenue: FY25 $11.69B, +4.4% (FY24 $11.20B; FY23 $11.16B). Steady low-single-digit top line; the 2021→2024 jump to ~$11B has since plateaued.
- The FY25 earnings shock (the whole story): net income collapsed to $883M (EPS diluted $4.34) from FY24's $2.22B / $10.94 — a ~60% drop — driven by record cocoa costs and ~$2.08/share of derivative mark-to-market losses on cocoa hedges (per the 8-K). Revenue rose; profit halved. This is a margin/commodity event, not a demand event.
- Quarterly recovery underway: Q1'26 revenue $3.10B (+10.6%), GAAP EPS $2.13 (+93.6% off a weak comp), adjusted EPS $2.35 (+12.4%); reported gross margin rebounded to 39.4% (+570 bps YoY) as pricing and lower derivative losses kicked in. Q1 beat the $2.04 Street estimate.
- Margins (TTM): gross 34.8%, EBITDA 18.1%, net 9.1% — all depressed vs Hershey's historical ~45% gross / ~16% net; the recovery to normalized margins is exactly what the estimates price.
- Cash flow: FY25 operating CF $2.28B, capex −$528M, FCF ~$1.75B (FCF yield ~4.7–5.9%). Cash generation held up far better than GAAP earnings — the derivative losses were largely non-cash — which is the reassuring tell that the dividend is safe.
- Balance sheet: total debt $5.40B, net debt $4.48B, net-debt/EBITDA 2.1× (TTM). Investment-grade and serviceable (interest coverage ~7.8×), but not a fortress — leverage rose as EBITDA fell.
- Dividend: ~$5.64/share, ~3.1% yield; TTM payout ratio is >100% on depressed GAAP EPS but comfortably covered on adjusted EPS and FCF. Watch this if the recovery stalls.
6. Valuation — priced in or room?
HSY screens optically expensive on trailing GAAP (33× P/E, 7.6× book) — but that P/E is on cocoa-depressed earnings and is misleading. The honest lens is forward, adjusted: on today's ~$182, forward P/E is ~22× FY26E ($8.43) → ~18× FY27E ($9.96) → ~15× FY30E ($12.41). EV/EBITDA is 19× TTM (elevated on depressed EBITDA), normalizing toward ~13× on FY27 estimates. EV/Sales 3.5× and P/FCF ~17× are middle-of-the-road for a premium staple.
Versus its own history, HSY at ~22× forward adj EPS is near, not below, its typical staple multiple — so the 23% drawdown has removed the froth but not created deep value. FMP's letter rating is B (overall 3/5), dinged specifically on P/E (1/5), P/B (1/5) and debt/equity (1/5) — i.e. flagged as richly valued and levered, offset by solid ROE/ROA. Street targets (context): consensus $224 (high $260, low $182 — the low equals today's price). Our $199 base is deliberately below consensus: we don't pay a growth multiple for a ~3-4% grower mid-commodity-recovery. Not a value buy; a fairly-priced quality staple.
7. Technicals (from the tech block)
- Trend: down. $182.14 sits below the 50-DMA ($185.10) and 200-DMA ($193.50), and the 50 is below the 200 (death-cross posture). MACD −2.15 (negative).
- Location: −22.9% off the 52-week high ($236.28), only +12.5% off the 52-week low ($161.95); max drawdown from peak −34%. A laggard well off its highs, not a breakout.
- Momentum: RSI(14) 51 — neutral, neither oversold nor overbought; no technical "falling knife" or "stretched" signal.
- Relative strength (the tell): HSY +3.6% 12-mo vs SPY +20.6% and QQQ +30.3%; −10.2% 3-mo vs SPY +13.7%. Persistent, material underperformance of both the market and growth — classic defensive-laggard behavior in a risk-on tape.
- Read: technicals do not confirm a bull case; they show a defensive name stuck below both moving averages in a downtrend. No urgency to buy on the chart. A patient investor could wait for stabilization above the 50-DMA (~$185) or a retest of the $162 low.
8. Moat & competitive position
Hershey's moat is a genuine brand + shelf-space + scale advantage in US confectionery, where it holds category leadership and the aisle is effectively a two-to-three-player game. Reese's alone is one of the best-selling candy brands in America; that pricing power is what let Hershey push ~10 points of price in Q1'26 while losing only ~2 points of volume. The weaknesses: the category is volume-flat/declining (health trends, and the live debate over GLP-1 appetite suppression shrinking snack demand), the business is US-concentrated, and cocoa is a single-commodity input with no substitute — a structural margin vulnerability FY25 laid bare.
Peer set (FMP peers, market cap): Keurig Dr Pepper $45B, Sysco $41B, Kimberly-Clark $38B, Kenvue $38B, Archer-Daniels-Midland $37B, Kellanova $29B, Kraft Heinz $30B, Estée Lauder $30B, Ambev $48B, JBS $27B. Hershey (~$37B) is a mid-cap staple among these; it commands a premium multiple to most packaged-food peers (KHC, K, ADM trade far cheaper) — justified by brand strength and higher ROE, but it is not cheap relative to the group.
9. Management, capital allocation & guidance
- Capital allocation: return-of-capital tilt — ~$1.09B dividends and (in prior years) buybacks, against modest ~$528M capex. Balanced but leverage crept to 2.1× net-debt/EBITDA as EBITDA fell; watch that the dividend isn't defended with debt if the recovery lags. The LesserEvil acquisition (2025) extends the better-growing salty-snacks arm (~150 bps of 2026 sales-growth benefit, per guidance).
- Insider activity: the only insider transactions in the window are routine automatic sales by the Hershey Trust (Milton Hershey School), a 10%-owner selling small tranches (~$180/share, late June 2026) — this is the Trust's standard diversification program, not a management sentiment signal. No notable discretionary executive buying or selling in the sample.
- Management's own guidance (half-weighted — their own book): Hershey's Q1'26 8-K (2026-04-30) reaffirmed FY2026 outlook — this is a real earnings release, and here is what management said, treated as self-interested and half-weighted:
- Net sales growth +4% to +5% (incl. ~150 bps from LesserEvil); organic net sales growth +2.5% to +3.5%.
- Reported EPS growth +79% to +89% (flattered by the depressed 2025 base); adjusted EPS growth +30% to +35% → adjusted diluted EPS $8.20–$8.52 (vs $6.31 in 2025).
- Effective tax rate ~25–27%; interest expense ~$200–210M; capex ~$425–475M; ~$100M of Agility/Automation savings.
- CEO Kirk Tanner: "We kicked off the year strong and are on track to hit our financial targets for 2026… laser-focused on fueling core growth."
- Read: management's adjusted-EPS guide ($8.20–8.52) brackets the Street's FY26E $8.43 — the recovery is on plan through Q1, and Q1'26 adjusted EPS came in above estimate. Credible, but it is a recovery-to-normal guide, not an acceleration.
10. Catalysts & what to watch
- Next earnings: 2026-07-29 (Q2'26; Street EPS $1.46, revenue ~$2.64B). Q2 is seasonally the weakest quarter; the key lines are gross-margin trajectory and volume elasticity as price hikes annualize.
- Cocoa price: the single biggest swing factor — every move in the bean and in hedge mark-to-market flows straight to earnings.
- Volume/elasticity: whether ~10 points of price keeps sticking without accelerating volume declines (watch for GLP-1-driven category softness).
- Salty-snacks momentum: the growth adjacency; continued double-digit organic there supports the bull case.
- Dividend/leverage: payout coverage on adjusted EPS/FCF and whether net-debt/EBITDA trends back below 2×.
Thesis tripwires (what would change the call): two consecutive quarters of accelerating volume declines; adjusted gross margin failing to recover toward the high-30s/40s; a dividend funded increasingly by debt; or the stock breaking below the $162 52-week low on deteriorating fundamentals.
11. Key risks
- Cocoa-cost inflation (structural, the #1 risk): a single, non-substitutable input that halved FY25 GAAP earnings via cost and derivative mark-to-market. The entire recovery thesis assumes normalization.
- Volume elasticity / secular demand: candy is volume-flat to declining; aggressive pricing risks accelerating unit losses, and GLP-1 appetite suppression is a genuine long-term category overhang.
- Leverage: 2.1× net-debt/EBITDA is manageable but rose as EBITDA fell; less cushion than the low beta implies.
- Valuation: ~22× forward adjusted EPS for a ~3-4% grower leaves little margin for a recovery disappointment; the multiple could de-rate toward peers (KHC/K trade far lower).
- No expert corroboration: with zero KB claims, there is no independent analyst panel behind this name — the call rests solely on the quant/fundamental read, which is itself a (modest) source of uncertainty.
12. Verdict, position sizing & monitoring
Watch. Hershey is a high-quality, defensive brand machine trading at a fair (not cheap) price while it recovers from a genuine cocoa-cost shock. The dividend (~3.1%) is well-covered on cash flow, the balance sheet is investment-grade, and Q1'26 shows the margin recovery is on track — but the category is volume-flat, growth is low-single-digit, leverage sits at 2.1×, the chart is in a downtrend below both moving averages, the Street itself is a "Hold," and the Synthos KB has zero conviction voices to lean on. Nothing here argues for an urgent buy; nothing argues for panic selling a quality compounder either.
- Sizing: if owned, a defensive/income sleeve position, ~1–2% — a yield-and-stability holding, not a conviction bet. New money can wait for either a cheaper entry (toward the $162 low) or clearer evidence the margin recovery is sticking.
- Monitoring: re-underwrite on the §10 tripwires; formal re-score each earnings print, with special attention to cocoa/derivatives and volume elasticity. This verdict is logged as a tracked Synthos call as of 2026-07-03 at $182.14.
- Single biggest risk: cocoa-cost inflation — the input shock that halved FY25 earnings and on whose normalization the entire recovery rests.
Provenance & disclosures
- Traceability: 0 KB claims, breadth 0 — there is no expert coverage of HSY in the Synthos knowledge base, so no
claim_ids are cited. This is disclosed plainly rather than papered over; the verdict is fundamentals- and quant-driven. Fabricated conviction is structurally impossible (claim-ID reconciliation). - Data as-of: fundamentals 2026-03-29 (Q1'26) · estimates & prices 2026-07-02/03 · management guidance from the SEC 8-K dated 2026-04-30. Forward figures are analyst consensus (FMP) or management guidance, labeled as estimates.
- Management caveat: the FY2026 guidance in §9 is management's own, self-interested outlook, half-weighted by design; adjusted (non-GAAP) EPS excludes cocoa-derivative mark-to-market by management's own definition.
- Not investment advice. Independent research, educational and informational only, never personalized. Hypothetical/forward figures are labeled; the only performance numbers Synthos will headline are the live, real-money Flagship's.
- Version: 2026-07-03. Prior versions available via the deep-dive version dropdown ("based on the info at the time").